4th Pediatric Infectious Diseases Conference
 
 
Home  Back   ISSN 0973 - 0958
 
User name :
Password :
Pedi Poll
Today's Poll
Should teicoplannin, colistin be used in case of neonatal sepsis where culture does not reveal any organism_?
No, it should be used only after drug sensitivity report
Yes, under guidance of an infectious disease expert
INSULIN THERAPY IN CHILDREN
Insulin Therapy in Children
Dr H B Chandalia
Director,
Diabetes, Endocrine and Nutrition Management and Research Centre,
MK Road, Mumbai 400 021.
Consulting Endocrinologist and Diabetologist,
Jaslok, Breach Candy and Lilavati Hospitals, Mumbai.


Dr P S Lamba
Consultant Endocrinologist and Diabetologist,
Diabetes, Endocrine and Nutrition Management and Research Centre,
MK Road, Mumbai 400 021.


TYPES OF INSULIN :-

With the advent of human insulins, bovine or porcine insulins have hardly any role to play in the management of type 1 diabetes in children. Avoiding use of bovine and porcine insulins can successfully obviate the attendant problems of insulin resistance, insulin antibodies, and lipoatrophy.

The introduction of rapid acting insulin analogues, Lispro and Aspart insulin has further facilitated intensive glycemic control by their use in the MDI regimes (16-18) (Fig 2). Further, substituting regular insulin with these analogues can solve many a problem encountered in achieving adequate glycemic control. The foremost among these is a marked reduction in nocturnal hypoglycemic episodes. They also have a special role to play in cases of Somogyi phenomena, Dawn phenomena and brittle diabetes.

Ultralente insulin (bovine) was the closest we had to good basal insulin. However, it was still woefully inadequate. The introduction of Glargine insulin has shown great promise as it provides the near ideal, once a day, peakless, basal insulin.

Pulmonary aerosol (inhalant) insulin is the next major blessing for young diabetics (19). With its introduction, giving a single bedtime dose of Glargine insulin and metered doses of inhaled insulin prior to each meal/snack may further facilitate intensive control.

Mean Serum insulin concentration in non diabetic

Fig 2: Mean serum insulin concentration in non - diabetic subjects after subcutaneous injection (0.2 U/kg) of human insulin Aspart (¨) and regular human insulin (o ) at various sites. A. Abdomen B. Deltoid C. Thigh. (20)

Insulin Therapy References
1. Shah SC, Malone JI, Simpson NE. A randomized trial of intensive insulin therapy in newly diagnosed insulin dependent diabetes mellitus. N Eng J Med 1989; 320-4.
Insulin Therapy References
2. The Diabetes Control and Complication Trial research group. The effect of intensive treatment of diabetes on the development of progression of long-term complications in insulin dependent diabetes mellitus. N Eng J Med 1993; 329; 977-86.
Insulin Therapy References
3. Ohkubo Y, Kishikawa H, Araki E et al. Intensive insulin therapy prevents progression of diabetic microvascular complications in Japanese patients with non-insulin dependent diabetes mellitus: a randomized prospective six year study. Diabetes Res Clin Pract 1995; 28; 103-17.
Insulin Therapy References
4. Turner R, Cull C, Holman R. United Kingdom Prospective Diabetes Study 17: A nine year update of a randomized control trial on the effect of improved metabolic control on complication in non insulin dependent diabetes mellitus. Ann Intern Med 1996; 33; 438-43.
Insulin Therapy References
5. The DCCT research group. Epidemiology of severe hypoglycemia in the diabetes control and complications trial. Am J Med 1991; 90; 450-9.
Insulin Therapy References
6. Amiel SA, Tamborlane WV, Simonson DC et al. Defective glucose counter regulation after strict glycemic control of insulin dependent diabetes mellitus. N Eng J Med 1987; 316; 1376-83.
Insulin Therapy References
7. The DCCT research group. Weight gain associated with intensive therapy in diabetes control and complication trial. Diabetes Care 1988; 11; 567-73.
Insulin Therapy References
8. Mecklenberg RS. Acute complications associated with the use of insulin infusion pumps. Endocrinologist 1991; 1; 19-24.
Insulin Therapy References
9. Chandalia H. B. Insulin therapy in Diabetes Mellitus. Bombay Hosp. Jour. 18 : 39, 1976.
Insulin Therapy References
10. Chandalia H. B.: Insulin Delivery Systems In Current concepts in Diabetes Mellitus. Ed : Sainani G. S., Indian College of Physicians, Bombay, 1993, p. 131-142.
Insulin Therapy References
11. Gale EAM, Tattersall RV. Unrecognized nocturnal hypoglycemia in insulin treated diabetics. Lancet 1979; 1; 1049-52.
Insulin Therapy References
12. Owens DR, Barnett A. Designer insulins: have they revolutionized insulin therapy? In Batterdge JD ed. Diabetes-current perspectives. London; Martin Dunilitz 1999.
Insulin Therapy References
13. Heinemann L, Linkeschova R, Rave K et al. Time action profile of the long acting analogue insulin Glargine (HOE 901) in comparison with those of NPH insulin and placebo. Diabetes Care 2000; 23; 644-9.
Insulin Therapy References
14. Dashora U, Dashora V. insulin Glargine. Int J Diabetes Developing Countries 2000; 20; 140-4.
Insulin Therapy References
15. Herold KC, Polonsky KS, Cohen RM et al. Variable deterioration in cortical function during insulin-induced hypoglycemia. Diabetes 1985; 34; 677-85.
Insulin Therapy References
16. Howey DC, Bowsher RR, Brunelle RL et al. [Lys (B28)Pro(B29)] Human insulin. A rapidly absorbed analogue of human insulin. Diabetes 1994; 43; 396-402.
Insulin Therapy References
17. Fineberg SE, Fineberg NS, Anderson JH et al. Insulin immune response to LYSPRO human insulin therapy in insulin native type 1 and type 2 patients. Diabetologia 1995; 38(Suppl 1): A78.
Insulin Therapy References
18. Uwe B, Ebraham S, Hirschberger S et al. Effect of rapid acting insulin analogue, insulin Aspart on quality of life and treatment satisfaction in type 1 diabetic patients. Diabetes 1999; 48 (Suppl 1); Abs 0481; A112.
Insulin Therapy References
19. Weiss SR, Berger S, Cheng S-L et al. Adjunctive therapy with inhaled human insulin in type 2 diabetic patients failing oral agents. A multicentric phase II trial. Diabetes 1999; 48 (Suppl 1) A 12.
Insulin Therapy References
20. Mudaliar SR, Strange P. Lindberg FA et al. Insulin Aspart : a fast acting analogue of human insulin. Diabetes Care 1999; 22; 1501-6.
Last created on 23-02-2001
Last updated on 27-04-2007
 
 
Educational Section
 
Disclaimer:
The information given by www.pediatriconcall.com is provided by medical and paramedical & Health providers voluntarily for display & is meant only for informational purpose. The site does not guarantee the accuracy or authenticity of the information. Use of any information is solely at the user's own risk. The appearance of advertisement or product information in the various section in the website does not constitute an endorsement or approval by Pediatric Oncall of the quality or value of the said product or of claims made by its manufacturer.
 
copyright ©2011 website design & development by Levioza
Follow Us
Follow us on :
Folllow Us